Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and Aripiprazole for Irritability in Children with ADHD and Emotion Dysregulation
NCT05974241Phase 4Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Apr 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, aripiprazole in attention deficit hyperactivity disorder (ADHD), adjustment disorder (AD), sponsored by Tri-Service General Hospital. Started Apr 2017; status: completed.
02
Drugs
methylphenidatearipiprazole
03
Conditions
attention deficit hyperactivity disorder (ADHD)adjustment disorder (AD)
Beyond the preview
Go deeper on NCT05974241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05974241.